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Introduction. Inflammation in dental pulp cells (DPCs) initiated by Lipopolysaccharide (LPS) results in dental pulp necrosis. So
far, whether there is a common system regulating inflammation response and tissue regeneration remains unknown. miR-146a is
closely related to inflammation. Basic fibroblast growth factor (bFGF) is an important regulator for differentiation. Methods. To
explore the effect of miR-146a/bFGF on inflammation and tissue regeneration, polyethylene glycol-polyethyleneimine (PEG-PEI)
was synthesized, and physical characteristics were analyzed by dynamic light scattering and gel retardation analysis. Cell absorption,
transfection efficiency, and cytotoxicity were assessed. Alginate gel was combinedwithmiR-146a/PEG-PEI nanoparticles and bFGF.
Drug release ratio was measured by ultraviolet spectrophotography. Proliferation and odontogenic differentiation of DPCs with
1 𝜇g/mL LPS treatment were determined. Results. PEG-PEI prepared at N/P 2 showed complete gel retardation and smallest particle
size and zeta potential. Transfection efficiency of PEG-PEI was higher than lipo2000. Cell viability decreased as N/P ratio increased.
Drug release rate amounted to 70% at the first 12 h and then maintained slow release afterwards. Proliferation and differentiation
decreased in DPCs with LPS treatment, whereas they increased in miR-146a/bFGF gel group. Conclusions. PEG-PEI is a promising
vector for gene therapy. miR-146a and bFGF play critical roles in inflammation response and tissue regeneration of DPCs.
1. Introduction
Dental pulp cells (DPCs) are clonal precursors of dental pulp
tissue, possessing self-renewal and multilineage differentia-
tion capability. DPCs could differentiate into odontoblasts,
adipocytes, chondrocytes and neurons, and so forth [1]. Lipo-
polysaccharide (LPS), one of the central regulators of pulpal
pathogenesis, can bind to Toll-like receptor 4 (TLR4), to
initiate inflammatory cascade through mediating synthesis
and secretion of various inflammatory cytokines, causing
damage or even necrosis of dental pulp [2]. Vital pulp pro-
vides biological defense and maintains pulp pressure against
infection. However, once the inflammation spreads in pulp
chamber and irreversible pulpitis establishes, the success
rate of vital pulp therapy (VPT) decreases and saving teeth
becomes very difficult [3].Thus we speculate whether there is
a mechanism to repress inflammation response and enhance
tissue regeneration.
miR-146a is a newly discovered small RNA molecule
closely related to inflammation and immune diseases. miR-
146a is predicted to base-pair with sequences in the 3󸀠UTR
of the IL-1 receptor associated kinase 1 (IRAK1) and TNF
receptor associated factor 6 (TRAF6) and acts as a fine tuning
adaptor to prevent overstimulation of inflammatory response
[4, 5]. Basic fibroblast growth factor (bFGF) is involved in
multiple biological processes including cell survival, tissue
regeneration, wound healing, inflammation, and immune
response [6]. bFGF is an important factor for stimulating
proliferation and differentiation of DPCs, participating in
reparative dentin formation and repair of dental pulp [7].
Nevertheless, bFGFwith a short half-life value is unstable and
easy to degrade in vivo. Thus maintaining appropriate release
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concentration and time of bFGF through a delivery system is
necessary [8].
Successful gene delivery relies on effective gene delivery
vector. Viral vectors with high transfection efficiency are
commonly applied for gene delivery. Nevertheless, viral
vectors have side effects including immunogenicity, compli-
cated synthesis procedure, and carcinogenicity [9]. In recent
years, nonviral gene vectors with low immunogenicity, sim-
plicity of synthesis, and ease of large-scale production have
overcomeproblems occurringwith viral vectors and attracted
more attention [10]. PEI, a commonpolycation, possesses low
cytotoxicity, high transfection efficiency, and pH buffering
capacity. PEI is commonly applied for drug delivery, coat-
ing magnetic nanoparticles or transfection agent [11, 12].
Polyethylene glycol-polyethyleneimine (PEG-PEI) possesses
superior property of reduced cytotoxicity, increased trans-
fection efficiency, improved cell viability and polymer solu-
bility, prolonged circulation time, and decreased nonspecific
interaction with serum proteins [11]. Alginate, a linear het-
eropolysaccharide with high biocompatibility, is often used
to generate hydrogel for the delivery of drugs and proteins
[13]. The fine fabricated three-dimensional PEG-PEI alginate
hydrogel could mimic natural microenvironment, deliver
miRNAs and proteins to the cells, and promote cell-cell and
cell-matrix interaction [14].
In our previous study, we revealed that Oct4B1 played
a critical role in inflammatory response of DPCs through
interaction with miRNAs [15]. However, so far little is known
about the mechanism underlying the effect of miR-146a/
bFGF on inflammation response and tissue regeneration of
DPCs, as well as the potential application of PEG-PEI alginate
hydrogel in dental regeneration. Therefore, in this study, we
investigate the modulatory role of miR-146a and bFGF in
DPCs with inflammation response. Alginate gel was used as
a carrier to combine miR-146a/PEG-PEI nanoparticles and
bFGF and explore their effect on cell proliferation and odon-
togenic differentiation of DPCs treated with LPS. The data
generated from the present study will open novel possibility
to repress inflammatory reactions and enhance regeneration,
which would make it possible to replace current endodontic
strategies with tissue engineered dental pulp.
2. Materials and Methods
2.1. Isolation and Expansion of HumanDPCs. Normal human
premolars and impact third molars were collected and DPCs
were isolated from healthy young adults (13–28 years) under-
going orthodontic treatment in the Department of Oral and
Maxillofacial Surgery, the Affiliated Stomatology Hospital
of Sun Yat-sen University, with informed consent obtained
from each patient as previously described [16]. The protocols
were approved by the University Ethic Committee. Briefly,
DPCs were cultured in D-Modified Eagle’s Medium (DMEM,
GIBCO-BRL Life Technologies, Breda, Netherlands) sup-
plemented with 20% fetal bovine serum (FBS, Invitrogen,
CA, USA), 10U/mL penicillin, and 10mg/mL streptomycin
(Sigma, St. Louis, MO, USA) and incubated at 37∘C in 5%
CO
2
. The medium was changed every 3 days.
2.2. Synthesis of PEG-PEI Nanoparticles. Polyethylene glycol-
polyethyleneimine (PEG 2 kDa, PEI 25 kDa) was synthesized
according to the procedures as previously reported [17].
Briefly, PEG-PEI was synthesized through adding 1.25 g of
hyperbranched polyethyleneimine and 0.5 g of mPEG-N-
hydroxysuccinimide (NHS, 2mmol) to phosphate-buffered
saline (pH 7.4) and magnetically stirred at room temperature
overnight. The solution was purified by membrane dialysis
(3.5 kDa) in distilled water for 48 h and lyophilized to obtain
the PEG8k-PEI25k product. PEG-PEI was characterized
by 1H-NMR (Varian Mercury 30mHz NMR spectrometer,
Mountain View, CA, USA) in deuterium oxide. Fourier
transform infrared measurement was carried out by Fourier
transform infrared analyzer (Nicolet/Nexus 670, Woodland,
CA, USA) by the KBr method.
2.3. Preparation of miR-146a Loaded PEG-PEI Nanoparticles.
miR-146a/PEG-PEI nanoparticles were prepared and the
physical characteristics were analyzed. Briefly, a predeter-
mined (3 𝜇L 20𝜇M) amount of miRNA was added to a
vial containing the cationic micelle solution. Various micelle
concentrations were used in the preparation, according to the
designed nitrogen-to-phosphorus (N/P) ratio. The mixture
was vortexed and maintained at room temperature for 30m
and then stored at 4∘C before use.
2.4. Determination of the Particle Size and Zeta Potential
of miR-146a/PEG-PEI Nanoparticles with Various N/P Ratio.
Theparticle size and zeta potential of the preparedmiR-146a/
PEG-PEI nanocomplexes were determined by dynamic light
scattering (DLS). Measurements were performed at 25∘C
on BI-200 SM equipment (Brookhaven Instruments Cor-
poration, NY, USA). For the zeta potential measurement, a
standard electrophoresisminicell fromBrookhavenwas used.
The data for particle size and zeta potential were collected
on an autocorrelator with a detection angle of scattered light
at 90∘. All measurements were conducted in triplicate and
averaged to yield the mean particle size and zeta potential.
Prior to zeta potential analysis standard control samples were
run on the instrument.
2.5. Agarose Gel Retardation Assay. In order to evaluate the
miRNA complexation ability of the delivery agents, gel
electrophoresis was performed. The 3 𝜇L 20𝜇M of miRNA
was mixed with PEG-PEI complexes prepared at designated
N/P ratios (0, 0.1, 0.2, 0.5, 1.0, 2.0, and 5.0) without dilution.
Loading buffer was added to the samples. The samples were
loaded onto 1% agarose gel stained with 2.0 𝜇L ethidium
bromide solution and electrophoresed at 100V for 30m. An
ultraviolet image station (Olympus, Tokyo, Japan) was used
to record the gel images.
2.6. Evaluation of Transfection Efficiency by Flow Cytometry.
Flow cytometry analysis was employed to quantify the trans-
fection efficiency of nanoparticles in DPCs. DPCs at passage
3 were cultured in 6-well plates at a density of 2 × 105/well
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for 24 h before transfection until they reached 60%–70% con-
fluence. The cy3-miRNA/PEG-PEI nanoparticles and cy3-
miRNA negative control were synthesized by RiboBio Co.,
Ltd. (RiboBio, Guangzhou, China). Briefly, the process of
oligonucleotide synthesis is implemented as automated solid-
phase synthesis using phosphoramidite method as previously
reported [18]. miR-146a was diluted in acetate buffer, and
chitosan solution was added and stirred for 1 h at room tem-
perature. Particles were formulated by cy3-labeled miRNA
specific to enhanced green fluorescent protein (eGFP). The
experiment groups were incubated in cy3-miRNA/PEG-PEI
nanoparticles with the N/P ratio of 0.5, 2, 5, and 20 in 400 𝜇L
PBS (pH 7.4), respectively. Lipofectamine 2000 (lipo2000,
Invitrogen, Carlsbad, CA, USA) was used as positive con-
trol miRNA delivery agent, and normal medium served as
negative control. The amount of each sample was 100 pmol.
After 6 h incubation, DPCs were harvested by trypsinization,
washed in cold PBS, and fixed in 70% alcohol for 30min
on ice. After washing in cold PBS three times, cells were
analyzed on FACSCalibur flow cytometer (BD Biosciences,
San Jose, CA, USA), using 548 nm laser for excitation. 106
cells were analyzed in each group. Normally cultured cells
without nanocomplex transfection were used as negative
control for background calibration. The percentage of cells
internalized with nanocomplex or lipo2000 was determined
by the number of cy3-positive cells, and the transfection
efficiency (%) was analyzed using FCSExpress software.
2.7. Cellular Uptake of Nanoparticles Observed by Fluorescence
Microscope. To determine the cellular uptake of nanoparti-
cles, DPCs were cocultured with cy3-labeled miRNA/PEG-
PEI nanoparticles, and the absorption ratio was observed
under fluorescence microscope. DPCs were seeded in 6-well
plates at a density of 2 × 105/well. The nucleuses of cells were
stained with Hoechst 33342 for 10m and washed in PBS for
3 times. cy3-miRNA/PEG-PEI was prepared at designated
N/P ratio of 2. DPCs were incubated with the solution for
0, 1, 2, and 4 h. The images were captured under microscope
(Axiovert, Zeiss, Germany) to observe the cellular uptake of
nanoparticles.
2.8. Cell Viability Assay. DPCs were cocultured with miR-
146a/PEG-PEI nanoparticles for 48 h; their cytotoxicities
on DPCs were analyzed by CCK8 quantitative assay (Cell
Counting Kit-8, Dojindo, Kumamoto, Japan). DPCs were
cultured in 96-well plates at an initial density of 3 × 103/well
with normal DMEM medium for 24 h prior to PEG-PEI
induction. The experiment groups were incubated in cy3-
miRNA/PEG-PEI nanoparticles with the N/P ratio of 0.5, 1,
2, 5, 10, 20, 40, and 80, respectively. Normal medium served
as control. After 48 h incubation, cell viability was evaluated
by CCK8 according to manufacturer’s instructions. Briefly,
10 𝜇L of CCK8 solution was added to the culturemedium and
incubated for additional 2 h.The absorbance was determined
at 450 nm wave length and the cell viability was calculated
according to the formula: cell viability = (experiment group
OD value/control group OD value) × 100%.
2.9. Synthesis and Combination of Alginate Gel withmiR-146a/
PEG-PEI and bFGF. The alginate was synthesized as previ-
ously described [13]. Briefly, alginate solution was prepared
by dissolving 10mg of sodium alginate (FMC Biopolymer,
Philadelphia, PA, USA) in 1mL of distilled water. After
30min of ultrasonic stirring,miR-146a/PEG-PEI (50𝜇LmiR-
146a/PEG-PEI nanoparticles), bFGF (20 𝜇L bFGF), andmiR-
146a/bFGF/PEG-PEI (50𝜇L miR-146a/PEG-PEI nanoparti-
cles and 20 𝜇L bFGF)were added to the solution, respectively.
0.666 g CaCl
2
was added to distilled water and made into
20mL 0.3M solution with ultrasonic stirring. The alginate
was mixed with the solution and incubated for another 2 h.
The alginate beads were purified in distilled water for 3 times,
and the extra solution was abandoned.
2.10.The Drug Release Rate by Ultraviolet Spectrophotography.
The release profile of cy3-conjugated miR-146a/bFGF from
the hydrogel was measured using ultraviolet spectroscopy.
The hydrogel samples were incubated in PBS with pH = 7.4
at 37∘C for up to 24 h. Three-millilitre supernatants at the
desired time points (0, 1, 2, 3, 4, 5, 6, 8, 10, 12, and 24 h) were
collected and analyzed. Relative OD values were converted
into the actual weight of protein released by correlation with
a standard curve.
2.11. Cell Proliferation Assay. DPCs were cocultured with
prepared hydrogel in each group for 2 d and then incubated
in 1 𝜇g/mL LPS for 4 h. DPCs of control group (DPCs cul-
tured in normal medium), LPS group (DPCs with LPS stim-
ulation), miR-146a gel group (DPCs cocultured with miR-
146a/PEG-PEI alginate hydrogel and LPS stimulation), bFGF
gel group (DPCs cocultured with bFGF alginate hydro-
gel and LPS stimulation), and miR-146a/bFGF gel group
(DPCs cocultured with miR-146a/bFGF/PEG-PEI alginate
hydrogel and LPS stimulation) were cultured in 96-well plates
with DMEM supplemented with 10% FCS and 50mg/mL
gentamycin. Culture medium was changed every 3 d. Cell
proliferation was determined by CCK8 quantitative assay
(Cell Counting Kit-8, Dojindo, Kumamoto, Japan) according
to the absorbance (450 nm) of reduced 2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium (WST-8).
2.12. Effect of miR-146a/bFGF/PEG-PEI Alginate Hydrogel on
Odontogenic Differentiation of DPCs with Inflammation.
DPCs of each group were induced in odontogenic differen-
tiation medium containing DMEM supplemented with 15%
FBS, 10mmol/L 𝛽-glycerophosphate, 0.2mmol/L ascorbate-
2-phosphate, and 100 nmol/L dexamethasone (Sigma, St.
Louis, MO, USA) for 7 and 14 days. The mineral deposits
were detected by Alizarin red staining. Western blot was
used to determine the protein expression of odontogenic dif-
ferentiation markers DMP-1 and DSP.
For Alizarin red staining, cells were fixed with 4% para-
formaldehyde for 15min at room temperature and washed
with distilled water. 1% Alizarin red solution was added to
the fixed cells and incubated for 20min at room temperature
and then washed with distilled water. The stain was desorbed
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with 10% cetylpyridinium chloride (Sigma, St. Louis, MO,
USA) for 1 h. The solution was collected and distributed at
200mL/well on a 96-well plate, and absorbance readings
were taken at 590 nmusing a spectrophotometer. Alizarin red
levels were normalized to the total protein content.
Western blot was performed as described previously
[16]. Briefly, the total protein was measured by a Bio-Rad
Coomassie Blue protein assay (Bio-Rad Laboratories, Rich-
mond, CA, USA). Twenty micrograms of protein was diluted
by 10% bromophenol blue and boiled before being separated
by sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE) and transferred to a nitrocellulose mem-
brane. The membranes were blocked in 5% low-fat milk at
room temperature for 1 h, rinsed, and incubated with mono-
clonal antibodies mouse against human DMP-1 (1 : 500 dilu-
tion, Santa Cruz, CA, USA), rabbit against human DSP
(1 : 500 dilution, Santa Cruz, CA, USA), or human 𝛽-actin
(1 : 1000 dilution, Santa Cruz, CA, USA) overnight at 4∘C.
After washing, the membrane was incubated with the HRP-
conjugated secondary antibody (1 : 5000 dilution, Jackson
ImmunoResearch, PA, USA) at room temperature for 1 h.
Immunoreactive proteins were then visualized by incubating
membranes with electrogenerated chemiluminescence plus
detection agents (GE Healthcare, NJ, USA).
2.13. Statistical Analysis. All experiments were repeated at
least in triplicate. The SPSS19.0 software package (SPSS Inc.,
Chicago, IL) was used for the statistical tests. Student’s 𝑡-test
was applied to compare two samples. One-way analysis of
variance (ANOVA) was applied to compare the differences
among multiple samples. If equality of variances could be
assumed, Bonferroni test was performed. If equality of var-
iances could not be assumed, which was also concluded by
a hypothesis test, Kruskal-Wallis test was performed. The
difference was considered as being of statistical significance
at 𝑝 < 0.05.
3. Results
3.1. Synthesis of PEG-PEI Nanoparticles. PEG-PEI was syn-
thesized through the conjugation of PEG-NHS to PEI.
Figure 1(a) showed that strong characteristic peaks of PEG
and PEI reside at about 3.65 ppm (peak b) and 7.35 ppm
(peaks d and e), respectively, indicating that PEG was con-
jugated to the PEI chain.
3.2. Dynamic Diameter Distribution, Zeta Potential, and Elec-
trophoretic Mobility of miRNA-146a/PEG-PEI. Dynamic di-
ameter distribution, zeta potential, and electrophoretic
mobility of miRNA-146a/PEG-PEI were evaluated (Figures
1(b)–1(d)). Dynamic diameter distribution showed that
miRNA-146a/PEG-PEI nanoparticles were in the range 150–
360 nm at N/P ratio 1.5 to 40. The particle diameter of the
nanoparticles reached the lowest of 160 ± 5.37 nm at the
N/P ratio of 2 and maintained consistent upregulation with
the increasing of N/P value (Figure 1(b)). Similarly, the zeta
potentials were measured to about 0mV at the N/P ratio
of 2 and upregulated with the increasing of N/P value
(Figure 1(c)). Agarose gel electrophoresis image revealed
that the electrophoretic mobility was partially neutralized
and the bands were weakened with increase of N/P value.
The motion was completely retarded at N/P ratio of 2,
indicating full neutralization of the miRNA negative charge
(Figure 1(d)). PEG-PEI nanoparticles with low toxicity and
satisfied biocompatibility are preferable for gene delivery.
The miRNA-146a/PEG-PEI nanoparticles prepared at N/P 2
showed complete neutralization, smallest particle sizes and
zeta potential; thus N/P 2 was chosen for the following bio-
logical experiments.
3.3. Transfection Efficiency ofmiRNA-146a/PEG-PEI andmiR-
146a/lipo2000. Transfection efficiency ofmiRNA-146a/PEG-
PEI nanoparticles in DPCs was evaluated with flow cytom-
etry. Lipofectamine 2000 was used as positive control. The
transfection efficiencies appeared different at various N/P
ratios. As shown in Figures 2(a) and 2(b), transfection effi-
ciency increased along with the upregulation of N/P and
reached the peak (92.9% ± 2.4%) at N/P ratio of 5 and then
downregulated at N/P 20. Transfection efficiency percentages
of miRNA-146a/PEG-PEI nanoparticles were all over 80%,
which were higher than that of lipo2000 (76%) and negative
control group (0.9%) (𝑝 < 0.05), while there is no statistical
difference between these four experiment groups (𝑝 > 0.05).
These results indicated that the PEG-PEI transferred more
miRNA into cells than lipo2000; thus PEG-PEI might be a
valid gene delivery agent with better transfection efficiency
in DPCs than lipo2000.
3.4. Cell Uptake of cy3-miRNA-146a/PEG-PEI Nanoparticles.
The cell uptake of the cy3-miRNA-146a/PEG-PEI nanopar-
ticles was investigated at 0, 1, 2, and 4 h after transfection
using fluorescent microscopy. To evaluate the internalization
of miRNA into cells, cy3-labeled scrambled miRNA was
used (red fluorescence). The nucleus of DPCs was stained
with Hoechst 33342 (blue fluorescence). No red fluorescence
was expressed in negative control group (data not shown)
and cy3-miRNA-146a/PEG-PEI solution group after 0 h incu-
bation. After 1 h of incubation, cytoplasm of a few DPCs
revealed red fluorescence, which showed the intracellular
distribution of miRNA and delivery agents. After 2 h and
4 h, the number of cy3-positive cells increased and the DPCs
showed stronger red fluorescence in comparison with the 0 h
and 1 h groups (Figure 2(c)), indicating thatmoremiRNAwas
successfully shuttled into cells by PEG-PEI nanoparticles.
3.5. Cell Viability Analysis. The influence of miR-146a/PEG-
PEI on cell viability was examined by CCK8. DPCs were
exposed to miR-146a/PEG-PEI for 48 h at N/P ratios of 0.5,
1, 2, 5, 10, 20, 40, and 80 as shown in Figure 2(d). Cells
incubated in normal medium without treatment were served
as control, and the cell viability value was set at 100%. There
was no significant difference of cell viability between the
experiment groups and control group when the N/P ratio is
lower than 20 (𝑝 > 0.05). However, at N/P ratio of 40 and
80, the cell viability decreased to 71.23 ± 1.67% and 63.45 ±
2.03%, respectively, which were significantly downregulated
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Figure 1: Synthesis and characteristics of PEG-PEI. (a) Nuclear magnetic resonance graph of the products: (A) mPEG-CDI, (B) mPEG-PEI.
Strong characteristic peaks of PEG and PEI were shown to reside at about 3.65 ppm (peak b) and 7.35 ppm (peaks d and e), respectively.
(b) Dynamic diameter distribution showed that miR-146a/PEG-PEI nanoparticles were in the range 150–360 nm at N/P ratio 1.5 to 40. The
particle diameter of the nanoparticles was the lowest at the N/P ratio of 2 andmaintained consistent upregulation along with the increasing of
N/P value. (c) The zeta potentials were measured to 0mV at the N/P ratio of 2 and upregulated with the increasing of N/P value. (d) Agarose
gel electrophoresis image revealed that the electrophoretic mobility was partially neutralized and the bands were weakened with the increase
of N/P value. The motion was completely retarded at N/P ratio of 2.
compared with the control group (𝑝 < 0.05). This result
demonstrated that the cytotoxicity increased along with the
upregulation of N/P value.
3.6. Drug Release Profile of Alginate Hydrogel System. After
combining alginate gel with miR-146a/PEG-PEI nanoparti-
cles and bFGF, the drug release profile was examined. The
in vitro release experiment showed that the drug release of
bFGF, miR-146a, and miR-146a/bFGF amounted to more
than 70% at the beginning of the 12 h and maintained slow
release over 25 h (Figure 3(a)). This result indicated that
alginate hydrogel system is able to induce a sustained release
of bFGF, miR-146a, and miR-146a/bFGF.
3.7. Effect of miR-146a/bFGF/PEG-PEI Alginate Hydrogel Sys-
tem on Cell Proliferation of DPCs with Inflammation. As
shown in Figure 3(b), CCK8 results revealed that, comparing
with the control group, the OD value of LPS group signif-
icantly decreased at both 72 and 96 h after treatment (𝑝 <
0.05), indicating that LPS could restrain the cell proliferation
of DPCs. Both miR-146a gel and bFGF gel groups did not
show any significant difference (𝑝 > 0.05). However, the OD
value of miR-146a/bFGF gel group significantly increased at
both 72 and 96 h after treatment (𝑝 < 0.05), suggesting that
miR-146a/bFGF/PEG-PEI alginate hydrogel could effectively
promote cell proliferation of DPCs with LPS treatment.
3.8. Effect of miR-146a/bFGF/PEG-PEI Alginate Hydrogel Sys-
tem on Odontogenic Differentiation of DPCs with Inflam-
mation. Western blot showed that the protein expression
of DMP-1 and DSP revealed a similar expression pattern,
which was significantly downregulated in DPCs with LPS
treatment after 7 d and 14 d of LPS treatment compared with
control group (Figures 4(a1)–4(b3), 𝑝 < 0.001). After 7 d
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Figure 2: Transfection efficiency, cell uptake, and viability of DPCs incubated with miR-146a/PEG-PEI nanoparticles. ((a) and (b)) Flow
cytometry showed that transfection efficiency increased along with the upregulation of N/P and reached the peak (92.9%±2.4%) at N/P ratio
of 5 and then downregulated at N/P 20. Transfection efficiency percentages of miR-146a/PEG-PEI nanoparticles were all over 80%, which
were higher than that of lipo2000 (∗𝑝 < 0.05, ∗∗𝑝 < 0.001). (c) Cell uptake of DPCs incubated with cy3-miRNA/PEG-PEI nanoparticles.
Fluorescent images showed that no cy3-label red fluorescence was expressed in cy3-miRNA/PEG-PEI solution after 0 h incubation. After 1 h
of incubation, cytoplasm of a few DPCs revealed red fluorescence, which showed the intracellular distribution of miRNA and delivery agents,
whereas, after 2 h and 4 h, the number of cy3-positive cells increased and the DPCs showed stronger red fluorescence in comparison with
the 0 h and 1 h groups (×200). The nucleus of DPCs was stained with Hoechst 33342 (blue fluorescence). (d) Cell viability of DPCs treated
with miR-146a/PEG-PEI nanoparticles downregulated gradually along with the increasing of N/P ratio.There were no significant differences
between the experiment groups and control group when the N/P ratio was lower than 20 (𝑝 > 0.05). However, at N/P ratio of 40 and 80, the
cell viability decreased to 71.23 ± 1.67% and 63.45 ± 2.03%, respectively, which were significantly downregulated comparing with the control
group (∗𝑝 < 0.05).
of odontogenic induction, both DMP-1 and DSP did not
show any significant difference in miR-146a gel and bFGF
gel group (Figures 4(a1)–4(a3), 𝑝 > 0.05), while DMP-1 and
DSP were dramatically upregulated in miR-146a/bFGF gel
group (Figures 4(a1)–4(a3), 𝑝 < 0.05). After 14 d of odon-
togenic induction, DMP-1 expressionwas significantly down-
regulated in miR-146a gel group (𝑝 < 0.001) and upregulated
in miR-146a/bFGF gel group (𝑝 < 0.05), albeit showing no
significant difference in bFGF gel group (Figures 4(b1) and
4(b2), 𝑝 > 0.05), whereas DSP did not show any significant
difference inmiR-146a gel, bFGF gel, andmiR-146a/bFGF gel
groups (Figures 4(b1) and 4(b3), 𝑝 > 0.05).
TheAlizarin red staining revealed that, after 14 d of odon-
togenic induction, numerous mineralization deposits were
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Figure 3: Drug release profile and cell proliferation of DPCs with LPS treatment. (a) The in vitro drug release experiment showed that the
drug release of bFGF, miR-146a, and miR-146a/bFGF amounted to more than 70% at the beginning of the 12 h and maintained slow release
over 25 h. (b) CCK8 showed that, comparing with the control group, the OD value of LPS group significantly decreased at both 72 and 96 h
after treatment (∗𝑝 < 0.05). Both miR-146a gel and bFGF gel groups did not show any significant difference (𝑝 > 0.05), albeit the OD value
of miR-146a/bFGF gel group significantly increased at both 72 and 96 h after treatment (∗𝑝 < 0.05).
seen in all groups (Figures 4(c1)–4(d5)).The number of min-
eral nodules was downregulated in LPS group (Figures 4(c2)
and 4(d2)) compared with control group (Figures 4(c1) and
4(d1)). However, the number of mineral nodules showed
no difference among the miR-146a gel (Figures 4(c3) and
4(d3)), bFGF gel (Figures 4(c4) and 4(d4)), and control
group (Figures 4(c1) and 4(d1)). The number and average
size of mineral nodules were upregulated in miR-146a/bFGF
gel group (Figures 4(c5) and 4(d5)). These results indicate
that miR-146a/bFGF/PEG-PEI alginate hydrogel is effective
for promoting the odontogenic differentiation capability of
DPCs with inflammation.
4. Discussion
MicroRNAs (miRNAs) are small noncoding nucleotides neg-
atively regulating protein-coding gene expression at the post-
transcriptional level. Various studies have demonstrated that
miRNAs play important roles in the regulation of inflam-
matory and immune response triggered by bacterial sensing
[19]. The miR-146 family consisted of two evolutionary con-
served miRNA genes, miR-146a and miR-146b, locating on
chromosomes 5q33.3 and 10q24.32, respectively, in human.
miR-146a has been shown to be involved in cell prolifera-
tion, differentiation, apoptosis, inflammatory response, and
extracellular matrix metabolism [4, 5, 19]. Previous study
reported a 5- to 25-fold increase in the expression of miR-
146a and migration in DPCs with LPS stimulation, and LPS
is able to increase the migration of DPCs by modulating
the miR-146a-TRAF6/IRAK1 regulatory cascade [20]. miR-
146a is involved in regulation of the immune response stim-
ulated by LPS through negatively regulating NF-𝜅B, which
targets IRAK-1 and TRAF-6, resulting in reduction of proin-
flammatory cytokines TNF-a, IL-6, IL-1b, and MCP-1 [5].
miR-146a was upregulated in inflamed gingival tissue, down-
regulated the TLR signaling, and negatively regulated the
innate immune response [21]. However, since expression and
immune regulation of miRNAs exhibit tissue-specific pat-
tern [19], the underlying mechanism of miRNAs regulating
inflammation process and regeneration capability of DPCs
remains unknown.
Liposome and polycationic polymer-based nonviral sys-
tems are commonnonviral carrier with high biocompatibility
and little immunogenicity for delivering miRNA or siRNA
in vitro [10]. Compared with liposome, polymer-based non-
viral vectors have advantages in safety, potential large-scale
production, and physical stability [12, 22]. It is reported that
PEI produced transfection efficiency of 19% at N/P ratio of 8
in human adipose derived stem cells, which was higher than
that achieved by Lipofectamine [23]. PEG, with increased
biocompatibility, is also frequently applied to the coating of
magnetic nanoparticles [11]. In the present study, liposome, as
a commonly used commercial nonviral gene delivery vehicle,
was used as a positive control for the evaluation of trans-
fection efficacy. Our results confirmed that the transfection
efficiency of PEG-PEI nanoparticles at variousN/P valueswas
significantly higher compared to lipo2000, which agreedwith
the previous report [23].
Small size and low positive charge are beneficial for
easy cell uptake of nanoparticles, since low positive charge
could maintain the stability of nanoparticles in vivo, while
high positive charge nanoparticle may interact easily with
negatively charged molecules [24]. In the present study, cell
viability was above 85% at N/P of 0 to 20, demonstrating the
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Figure 4: Effect of miR-146a/bFGF/PEG-PEI alginate hydrogel on the odontogenic differentiation of DPCs with LPS treatment. ((a1)–(b3))
Western blot showed that the protein expression of DMP-1 and DSP was significantly downregulated in DPCs with LPS treatment after 7 d
and 14 d LPS treatment compared with control group (∗∗𝑝 < 0.001). After 7 d of odontogenic induction, both DMP-1 and DSP did not show
any significant difference in miR-146a gel and bFGF gel group ((a1)–(a3), 𝑝 > 0.05), albeit dramatically upregulated in miR-146a/bFGF gel
group ((a1)–(a3), ∗𝑝 < 0.05). After 14 d of odontogenic induction, DMP-1 expression was significantly downregulated in miR-146a gel group
(∗∗𝑝 < 0.001) and upregulated inmiR-146a/bFGF gel group (∗𝑝 < 0.05), albeit showing no significant difference in bFGF gel group ((b1)-(b2),
𝑝 > 0.05), whereas DSP did not show any significant difference in miR-146a gel and bFGF gel group and miR-146a/bFGF gel group ((b1) and
(b3), 𝑝 > 0.05). ((c1)–(d5)) Alizarin red staining revealed that, after 14 d of odontogenic induction, numerous mineralization deposits were
seen in all groups. The number of mineral nodules was downregulated in LPS group ((c2) and (d2)) compared with control group ((c1) and
(d1)). The number of mineral nodules showed no difference between the miR-146a gel ((c3) and (d3)), bFGF gel ((c4) and (d4)), and control
group ((c1) and (d1)), albeit the number and average size of mineral nodules were upregulated in miR-146a/bFGF gel group ((c5) and (d5)).
((c1)–(c5))The gross view of the samples with Alizarin red staining. ((d1)–(d5))The figures of the samples with Alizarin red staining observed
under inverted microscope (×100). ((c1) and (d1)) Control group, ((c2) and (d2)) LPS treated group, ((c3) and (d3)) miR-146a gel group, ((c4)
and (d4)) bFGF gel group, and ((c5) and (d5)) miR-146a/bFGF gel group.
low cytotoxicity and high biocompatibility ofmiR-146a/PEG-
PEI nanoparticles. Moreover, miR-146a/PEG-PEI nanoparti-
cles prepared at N/P 2 showed the complete neutralization,
smallest particle sizes, and zeta potential; thus N/P 2 was
chosen for the following biological experiments.
bFGF is involved in development, inflammation, wound
healing, cell proliferation, migration, osteogenic differenti-
ation, angiogenesis, and extracellular matrix formation [6–
8]. It is known that exogenous bFGF could maintain self-
renewal, high proliferation, and multilineage differentiation
potential of stemcells [25]. bFGF enhances stemness property
by increasing stem cell gene expression, cell proliferation,
and multilineage differentiation potency of stem cells from
the apical papilla (SCAP) [26]. bFGF induced in vivo recel-
lularization and revascularization in endodontically treated
human teeth, and DPCs could be recruited and subsequently
differentiated by stimulation of bFGF in the regeneration of
dental pulp [27].Moreover, bFGF, serving as a wound healing
factor in pain sensitization, was released during inflam-
mation and tissue regeneration [28]. The concentration of
bFGF was increased in arthritis rat models and patients,
as well as inflammatory bowel disease [29]. Expressions of
inflammation related molecules, including MMP-1, MCP-1,
IL-1ra, bFGF, and VEGF, were enhanced by costimulation
with proinflammatory cytokines IL-1𝛽 and IL-6 in human
gingival fibroblasts during gingival inflammation [30]. How-
ever, the short half-life value and easy degradation make it
difficult to maintain the slow release and sustain the effect of
bFGF on wound healing; thus it is necessary to apply a gene
delivery system.
Alginate, a linear heteropolysaccharide with high bio-
compatibility, is often used to generate hydrogel for the
delivery of drugs or proteins, and so forth. Alginate hydrogel
provides a suitable environment for tissue regeneration and
cell migration [13, 14]. It is reported that heparin and alginate
gelmaintained long term release of bFGFunder physiological
conditions in vitro [31]. Combined with the advantages of
PEG-PEI nanoparticles, a new PEG-PEI alginate hydrogel
complex was successfully developed. For the first time, the
alginate gel was used as a carrier to combine miR-146a/PEG-
PEI nanoparticles and bFGF and demonstrated that miR-
146a/bFGF/PEG-PEI alginate hydrogel is effective for pro-
moting the cell proliferation and odontogenic differentiation
of DPCs with inflammation. This result implies that a well-
designed PEG-PEI alginate hydrogel nanocomplex could
provide a microenvironment beneficial for improving tissue
regeneration capability of DPCs in response to inflammation.
Therefore, PEG-PEI alginate hydrogel could serve as a prom-
ising delivery vector for gene delivery in dental regeneration.
Furthermore, miR-146a/bFGF gel significantly enhanced
cell proliferation at various time points in DPCs with LPS
treatment and promoted odontogenic differentiation capabil-
ity through upregulating expression of DMP-1, DSP and the
formation of mineral nodules. However, miR-146a gel and
bFGF gel group did not show significant effect on prolifer-
ation and differentiation of DPCs. It might be possible that
miR-146a decreased the secretion of inflammation cytokines,
subsequently providing a microenvironment beneficial for
the positive effect of bFGFonodontogenic differentiation and
tissue regeneration. Therefore, miR-146a and bFGF might
BioMed Research International 11
work cooperatively to promote the regeneration capability
of DPCs in response to inflammation, whereas miR-146a or
bFGF solely is not sufficient to initiate this biological process.
Taken together, the present study revealed that PEG-PEI,
with low cytotoxicity, cellular adsorption properties, constant
protein release ratio, and high transfection efficiency, is a
promising nonviral carrier for potential gene therapy. miR-
146a/bFGF play an essential role in enhanced cell prolifera-
tion and odontogenic differentiation of DPCs in response to
inflammation, indicating thatmiR-146a and bFGFmight play
a critical cooperative role in the modulation of inflammation
response and regeneration of DPCs. New insights into the
interplay of inflammation response and tissue regeneration
will open novel therapeutic opportunities for dental patients.
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